48th ICAAC/IDSA 46th Annual Meeting Washington, DC October 25-28, 2008
HIV News at ICAAC/IDSA - Part 1
November 4, 2008
At the 2008 joint meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Disease Society of America (IDSA), Tim Horn speaks with Roy M. Gulick, MD, MPH, a professor of medicine at the Weill College of Medicine of Cornell University and the director of the Cornell Clinical Trials Unit in New York. In this first of a two-part interview, Dr. Gulick reviews some of the noteworthy HIV presentation at ICAAC/IDSA, including new data suggesting that antiretroviral therapy is most effective when started when the CD4 count falls below 500.
8 1/2 minutes. Transcript coming soon! To view Part 2, click here.
Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 1 (of 1 total)
florence Regasto, Cape Town, 2008-11-11 09:24:16
we have a young woman who was told recently that she has aids she has 2 small children can you advise what drugs food etc and understanding of the illness She says she wants to live and not to die
